Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores

Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores

Design of clinical trials requires careful decision-making across several dimensions, including endpoints, eligibility criteria, and subgroup enrichment. Clinical trial simulation can be an informative tool in trial design, providing empirical evidence by which to evaluate and compare the results of...

Полное описание

Библиографические подробности
Главные авторы:	Weinstein, SM, Coates, LC, Helliwell, PS, Ogdie, A, Stephens-Shields, AJ
Формат:	Journal article
Язык:	English
Опубликовано:	SAGE Publications 2021

Схожие документы

Psoriatic arthritis: prospects for the future
по: Hackett, S, и др.
Опубликовано: (2022)

Measuring outcomes in psoriatic arthritis
по: Ogdie, A, и др.
Опубликовано: (2020)

THE DIAGNOSIS OF PSORIATIC ARTHRITIS
по: P.S. Helliwell
Опубликовано: (2011-09-01)

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
по: Helliwell, PS, и др.
Опубликовано: (2022)

What should be the primary target of "treat to target" in psoriatic arthritis?
по: Coates, LC, и др.
Опубликовано: (2018)

Psoriatic arthritis: prospects for the future
по: Simon Hackett, и др.
Опубликовано: (2022-03-01)

Psoriatic arthritis
по: FitzGerald, O, и др.
Опубликовано: (2021)

Comparing the visual analogue scale and the numerical rating scale in patient-reported outcomes in psoriatic arthritis
по: Ye, W, и др.
Опубликовано: (2021)

Inhibition of interleukin-17 in patients with oligoarticular psoriatic arthritis
по: Ogdie, A, и др.
Опубликовано: (2023)

The role of ultrasound in psoriatic arthritis — do we need a score?
по: D'Agostino, MA, и др.
Опубликовано: (2019)

Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis
по: Coates, LC, и др.
Опубликовано: (2022)

Measuring physical function in psoriatic arthritis: comparing the Multi-Dimensional Health Assessment Questionnaire to the Health Assessment Questionnaire Disability Index
по: Ye, W, и др.
Опубликовано: (2021)

Current concepts and unmet needs in psoriatic arthritis
по: Mahmood, F, и др.
Опубликовано: (2017)

Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial
по: Coates, L, и др.
Опубликовано: (2019)

Evaluation and validation of a patient completed psoriatic arthritis flare questionnaire
по: Helliwell, PS, и др.
Опубликовано: (2021)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
по: Coates, L, и др.
Опубликовано: (2016)

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
по: Coates, L, и др.
Опубликовано: (2020)

Outcome measures in psoriatic arthritis: where next?
по: Hackett, S, и др.
Опубликовано: (2022)

Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis
по: Laure Gossec, и др.
Опубликовано: (2024-02-01)

Assessing disease activity in psoriatic arthritis: a literature review
по: Tucker, L, и др.
Опубликовано: (2018)

The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study
по: Helliwell, PS, и др.
Опубликовано: (2023)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
по: Gladman, DD, и др.
Опубликовано: (2022)

Classification and outcome measures for psoriatic arthritis
по: Leung, Y, и др.
Опубликовано: (2018)

Sex-specific differences in patients with psoriatic arthritis: a systematic review
по: Coates, LC, и др.
Опубликовано: (2022)

Hot topice debate: preventing psoriatic arthritis in patients with psoriasis
по: Vivekanantham, A, и др.
Опубликовано: (2024)

Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic review
по: Leung, Y-Y, и др.
Опубликовано: (2020)

Outcomes of the 2019 GRAPPA workshop on continuous composite indices for the assessment of psoriatic arthritis and membership: Recommended next steps
по: Tillett, W, и др.
Опубликовано: (2020)

How should we define disease and outcomes in axial psoriatic arthritis?
по: Coates, LC
Опубликовано: (2021)

Identification of psoriatic arthritis in patients with psoriasis
по: Coates, LC, и др.
Опубликовано: (2023)

GRAPPA 2021 treatment recommendations for psoriatic arthritis
по: Soriano, ER, и др.
Опубликовано: (2023)

The State of the Art - Psoriatic Arthritis outcome assessment in clinical trials and daily practice
по: Day, J, и др.
Опубликовано: (2022)

New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation
по: Coates, L, и др.
Опубликовано: (2016)

Psoriatic Arthritis: A Review
по: Farrouq Mahmood, и др.
Опубликовано: (2016-07-01)

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
по: Atul Deodhar, и др.
Опубликовано: (2022-07-01)

Obesity and Psoriatic Arthritis: A Narrative Review
по: Anand Kumthekar, и др.
Опубликовано: (2020-06-01)

Psoriatic arthritis in developing and resource-poor countries
по: Maharaj, AB, и др.
Опубликовано: (2020)

Methotrexate in psoriasis and psoriatic arthritis
по: Coates, L, и др.
Опубликовано: (2020)

Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis
по: Alexis Ogdie, и др.
Опубликовано: (2023-05-01)

Is axial psoriatic arthritis the same as ankylosing spondylitis with psoriasis: a debate
по: Coates, LC, и др.
Опубликовано: (2023)

Axial spondyloarthritis and psoriatic arthritis: mostly overlapping or substantially different diseases?
по: Braun, J, и др.
Опубликовано: (2023)